At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Not specified by the sponsor
- How long the study runs
- Study runs about 71 months (dates as stated)
- About the drug or intervention
- Not specified by the sponsor
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 360
- Started
- 2021-10-01
- Last checked
- 2024-02
Plain English Summary
What is this study?
- • Testing a new treatment for stroke, ischemic
- • Clinical study - 360 participants
- • Annually 100,000 strokes occur, placing stroke as the largest cause of disability in the UK
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with stroke, ischemic
Where?
- • Merthyr Tydfil - Prince Charles Hospital
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
Annually 100,000 strokes occur, placing stroke as the largest cause of disability in the UK. 90% of strokes are preventable, leading to national focus on programmes including "The National Stroke Programme" to act on preventing, treating, and improving post-stroke care. Importantly, over 25% of ischaemic stroke sufferers have previously had a Transient Ischaemic Attack (TIA), which presents the biggest concern for TIA patients. There are no measures which reliably identify TIA patients most likely to suffer a stroke. Novel biomarkers for predicting stroke are key to addressing this problem. The PREDICT-EV study aims to screen 300 TIA patients and follow them over 12-months. The investigators will determine if a novel biomarker we've identified to increase thrombotic risk (endothelial derived extracellular vesicles) and the resulting increased prothrombin time is associated with patients at highest risk of stroke.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓The inclusion criteria for phase 1 (initial patient recruitment) will be:
- ✓TIA confirmed patient has been prescribed antiplatelet drugs or anticoagulants.
- ✓Patients must be aged \> 18 years.
- ✓Patients are taking an ordinary diet by mouth.
- ✓The inclusion criteria for phase 2 (patient representing with stroke) will be:
See the full criteria
Where Is This Study? (1 UK site)
Prince Charles Hospital
Merthyr Tydfil CF479DT, United Kingdom
How to Get in Touch
Jessica Williams, PhD
Sponsor contactCONTACT
